Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 507-510, February 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, P. D.
Right arrow Articles by Lenard, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, P. D.
Right arrow Articles by Lenard, J.

Reduced Cytotoxicity of the Lysosomotropic Detergent N-Dodecylimidazole after Differentiation of HL60 Promyelocytes1

Patricia D. Wilson2, David Hreniuk and John Lenard

Department of Physiology and Biophysics, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School (formerly Rutgers Medical School), Piscataway, New Jersey 08854-5635

The sensitivity of the human promyelocytic cell line HL60 to killing by the lysosomotropic detergent N-dodecyl imidazole (C12-Im) has been investigated in the exponential and stationary growth states and before and after differentiation induced by suitable effector molecules. Undifferentiated HL60 cells were more sensitive to killing by C12-Im in the rapid (exponential) phase of growth than in the stationary phase, in keeping with our observations on many other cell lines. Differentiation into granulocytes induced by dimethyl sulfoxide, or into macrophages induced by phorbol ester, resulted in a further dramatic decrease in sensitivity to C12-Im, as compared to undifferentiated HL60 cells in stationary phase. Viable cells remaining after treatment with C12-Im (60 µg/ml, 2 h) were: 0% for exponentially growing undifferentiated cells; 16% for stationary undifferentiated cells; 41% for differentiated granulocytes; and 29% for differentiated macrophages. Treatment with the cysteine cathepsin inhibitor L-trans-epoxysuccinylleucylamido(4-guanido)butane (E64) conferred resistance to C12-Im, showing that, in these cells, as previously demonstrated for Chinese hamster ovary fibroblasts, cysteine proteases were major cytotoxic agents involved in killing by C12-Im. Cell cathepsin B + L activity levels were dramatically reduced in those cells differentiated into granulocytes (11.2 units/mg of protein) and into macrophages (9.8 units/mg of protein) as compared with undifferentiated HL60 promyelocytes in stationary phase (30.4 units/mg of protein), correlating well with reduced sensitivity to C12-Im in the differentiated cells.

1 This work was supported by NIH Grant GM 34050.

2 To whom requests for reprints should be addressed.

Received 6/ 8/88. Revised 10/21/88. Accepted 10/31/88.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
P. Kelk, A. Johansson, R. Claesson, L. Hanstrom, and S. Kalfas
Caspase 1 Involvement in Human Monocyte Lysis Induced by Actinobacillus actinomycetemcomitans Leukotoxin
Infect. Immun., August 1, 2003; 71(8): 4448 - 4455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.